Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.309EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.632EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.108EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.332EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
N/AEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.494EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.167EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.267EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.554EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.450EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.130EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.444EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.268EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.344EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.103EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.485EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.119EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.276EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.111EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.336EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.400.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.537EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.548EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.24.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.492EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.540EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.487EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.118EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.417EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.319EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used